Clincosm LogoSign in Get a demo

other solid tumors

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and

Not yet recruiting
  • HER2+ Advanced Breast Cancer
  • Other Solid Tumors
  • ADCC-R-Epo-R T-cells + Trastuzumab
  • +2 more
  • (no location specified)
Aug 31, 2023

Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

Not yet recruiting
  • Carcinoma
  • +7 more
  • XNW5004
  • Pembrolizumab 25 mg/mL Solution for Injection
  • (no location specified)
Aug 31, 2023

Advanced HCC, Other Solid Tumors Trial in Shanghai (KD6001, Tislelizumab, Bevacizumab)

Not yet recruiting
  • Advanced HCC
  • Other Solid Tumors
  • Shanghai, China
    Zhongshan Hospital
Jun 13, 2023

NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Autologous, engineered T Cells targeting TP53 R175H
  • Duarte, California
    City of Hope
May 17, 2023

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

Recruiting
  • Non-Small Cell Lung Carcinoma (NSCLC)
  • +2 more
  • Selinexor 100 mg
  • +6 more
  • Ashdod, Israel
  • +10 more
Jan 30, 2023

Locally Advanced or Metastatic Urinary Tumors, Other Solid Tumors Trial in Beijing (BL-B01D1)

Recruiting
  • Locally Advanced or Metastatic Urinary Tumors
  • Other Solid Tumors
  • Beijing, Beijing, China
  • +3 more
Jan 11, 2023

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

NSCLC, Other Solid Tumors Trial in Australia (GB263T)

Recruiting
  • NSCLC
  • Other Solid Tumors
  • GB263T
  • Saint Leonards, New South Wales, Australia
  • +3 more
Aug 3, 2022

Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer Trial in Worldwide (PDR001)

Completed
Has Results
  • Melanoma
  • +4 more
  • PDR001
  • Baltimore, Maryland
  • +40 more
Aug 2, 2022

Melanoma, Merkel Cell Carcinoma, Other Solid Tumors Trial in Middletown, Harrison, New York (TALIMOGENE LAHERPAREPVEC (TVEC),

Active, not recruiting
  • Melanoma
  • +2 more
  • TALIMOGENE LAHERPAREPVEC (TVEC)
  • Hypofractionated Radiotherapy
  • Middletown, New Jersey
  • +2 more
Jul 13, 2022

Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer Trial in Australia, Canada, United States (IDE196, Binimetinib,

Recruiting
  • Metastatic Uveal Melanoma
  • +3 more
  • Scottsdale, Arizona
  • +13 more
May 10, 2022

Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +4 more
  • Aurora, Colorado
  • +2 more
Apr 18, 2022

NSCLC, Colorectal Cancer, Pancreatic Ductal Carcinoma Trial in United States (JAB-3312)

Recruiting
  • Non-small Cell Lung Cancer
  • +6 more
  • Denver, Colorado
  • +3 more
Mar 13, 2022

NSCLC, Colorectal Cancer, Pancreatic Ductal Carcinoma Trial in Beijing, Henan (JAB-3312)

Recruiting
  • Non-small Cell Lung Cancer
  • +6 more
  • Beijing, Beijing, China
  • +4 more
Dec 28, 2021

Part 1, MELANOMA, SCCHN Trial in Worldwide (PF-06801591)

Completed
Has Results
  • Part 1
  • +8 more
  • Los Angeles, California
  • +66 more
Oct 29, 2021

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
Has Results
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Ovarian Tumors, Non-Small-Cell Lung Carcinoma, Melanoma Trial in Worldwide (LTT462)

Terminated
Has Results
  • Ovarian Neoplasms
  • +3 more
  • New York, New York
  • +6 more
Aug 15, 2019

Advanced NSCLC, Other Solid Tumors Trial (VELCADE TM (bortezomib) for Injection, or PS-341)

Terminated
  • Advanced Non-Small Cell Lung Cancer
  • Other Solid Tumors
  • VELCADE TM (bortezomib) for Injection, or PS-341
  • (no location specified)
Jun 23, 2005